key: cord-0821548-qws7j38g
authors: Schatzman, Austin; Vandenheuvel, Julia; Villalobos, Tibisay; Rooney, Kris
title: Transient leukopenia, thrombocytopenia, and severe neutropenia associated with acute SARS‐CoV‐2 infection
date: 2021-06-20
journal: Pediatr Blood Cancer
DOI: 10.1002/pbc.29105
sha: 89395946886de99f9099904e750d701cfa9e3f7b
doc_id: 821548
cord_uid: qws7j38g

nan

To the Editor:

Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been reported to cause a myriad of manifesta- in GATA 1 are well recognized in trisomy 21 to cause megakaryocyte and erythroid abnormalities but not myeloid. 13 Thus, the presence of leukopenia, thrombocytopenia, and severe neutropenia in our patient remain novel findings. Rapid bone marrow response occurred without

SARS-CoV-2 infection in two pediatric patients with immune cytopenias: a single institution experience during the pandemic

COVID-19-associated pancytopenia can be self-limiting and does not necessarily warrant bone marrow biopsy for the purposes of SARS-CoV-2 diagnostics

Mechanism of thrombocytopenia in COVID-19 patients

Hematological manifestations of SARS-CoV-2 in children

Severe neutropenia in infants with severe acute respiratory syndrome caused by the novel coronavirus 2019 infection

Can COVID-19 cause severe neutropenia?

Post-COVID-19 severe neutropenia

Influenza-induced thrombocytopenia is dependent on the subtype and sialoglycan receptor and increases with virus pathogenicity

Review article: the pathophysiology of thrombocytopenia in hepatitis C virus infection and chronic liver disease

Coxsackievirus B3 infects the bone marrow and diminishes the restorative capacity of erythroid and lymphoid progenitors

Neutropenia in pediatric practice

Altered hematopoiesis in trisomy 21 as revealed through in vitro differentiation of isogenic human pluripotent cells

Pathologic features of down syndrome myelodysplastic syndrome and acute myeloid leukemia: a report from the Children's Oncology Group Protocol AAML0431